Observational studyRenal failure2026
Frailty index and type 2 diabetes with renal complications: insights from Mendelian randomization and retrospective observational study.
Observational study in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo investigate the relationship between frailty and diabetic kidney disease (DKD)-related renal complications using Mendelian randomization (MR) and complementary clinical analysis.
methodsTwo-sample MR was performed using genome-wide association study summary statistics to assess the association between genetically predicted frailty and type 2 diabetes with renal complications. Functional annotation and sensitivity analyses, including exclusion of potentially pleiotropic variants and multivariable MR, were conducted. A retrospective hemodialysis cohort (
resultsGenetically predicted frailty was significantly associated with increased risk of type 2 diabetes with renal complications (inverse-variance weighted odds ratio = 5.30, 95% confidence interval: 1.89-14.91,
conclusionsFrailty was associated with DKD-related renal complications, and forward MR suggested a potential causal contribution. Frailty may represent a clinically relevant marker of systemic vulnerability in this setting, although further validation in larger prospective cohorts is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.